Prescription patterns of diuretics in chronic heart failure: A contemporary background as a clue to their role in treatment

Journal of Cardiac Failure

Volumn 9, Issue 3, 2003, Pages 210-218

  Faggiano, Pompilio ^a,j   Opasich, Cristina ^b   Tavazzi, Luigi ^c   Achilli, Felice ^d   Gentile, Anna ^e   De Biase, Luciano ^f   De Maria, Renata ^g   Pozzi, Roberto ^h   Tarantini, Luigi ⁱ   Gonzini, Lucio ^j   Maggioni, Aldo P ^j  

^a SPEDALI CIVILI   (Italy)

^b IRCCS   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e Sestri Levante Hospital   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g CNR   (Italy)

^h SAN LUIGI GONZAGA HOSPITAL   (Italy)

ⁱ SAN MARTINO HOSPITAL   (Italy)

^j ANMCO RESEARCH CENTER   (Italy)

more..

Author keywords

Aldosterone receptor blockers; Diuretics; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CANRENOATE POTASSIUM; CANRENONE; CHLORTALIDONE; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETACRYNIC ACID; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOOP DIURETIC AGENT; METOLAZONE; NITRATE; PIRETANIDE; POTASSIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0037937392     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2003.25     Document Type: Article

References (28)

1. Anand IS, Kalra GS, Ferrari R, Wahi PL, Harris PC, Poole-Wilson PA. Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. Int J Cardiol 1990;28:341-6.
2. Cowley AJ, Stainer K, Wynne RD, Rowley JM, Hampton JR. Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Lancet 1986;2:770-2.
3. Gerlag PG, van Meijel JJ. High-dose furosemide in the treatment of refractory congestive heart failure. Arch Intern Med 1988;148:286-91.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
5. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
6. CIBIS II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study (CIBIS II), a randomised trial. Lancet 1999;353:9-13.
7. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT HF). Lancet 1999;353:2001-7.
8. Hunt HA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2001;104:2996-3007.
9. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987;57:17-22.
10. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990;82:1724-9.
11. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999;100:1311-5.
12. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
13. Opasich C, Tavazzi L, Lucci D, Gorini M, Albanese MC, Cacciatore G, et al. Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol 2000;86:26-30.
14. The Task Force on Heart Failure of the European Society of Cardiology. The diagnosis of heart failure. Eur Heart J 1995;16:741-51.
15. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997;18:736-53.
16. Walma EP, Hoes AW, van Dooren C, Prins A, van der Does E. Withdrawal of long term diuretic medication in elderly patients: a double blind randomised trial. BMJ 1997;315:464-8.
17. Grinstead WC, Francis MJ, Marks GF, Tawa CB, Zoghbi WA, Young JB. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 1994;73:881-6.
18. van Kraaij DJ, Jansen RW, Bouwels LH, Gribnau FW, Hoefnagels WH. Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function. Am J Cardiol 2000;85:1461-6.
19. Braunschweig F, Linde C, Eriksson MJ, Hofmann-Bang C, Rydén L. Continuous hemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J 2002;23:59-69.
20. Dzau VJ, Hollenberg NK. Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. Ann Intern Med 1984;100:777-82.
21. Good JM, Brady AJB, Noormohamed FH, Oakley CM, Cleland JG. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition. Circulation 1994;90:220-4.
22. Kramer B, Schweda F, Riegger GA. Diuretic treatment and diuretic resistance in heart failure. Am J Med 1999;106:90-6.
23. Knauf H, Mutschler E. Sequential nephron blockade breaks resistance to diuretics in edematous states. J Cardiovasc Pharmacol 1997;29:367-72.
24. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65.
25. MacFadyen RJ, Barr CS, Struthers AD. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 1997;35:30-4.
26. Ramires FJ, Mansur A, Coelho O, Maranhao M, Gruppi CJ, Mady C, et al. Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 2000;85:1207-11.
27. Farquharson CA, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 2000;101:594-7.
28. Philbin EF, Jenkins PL. Differences between patients with heart failure treated by cardiologists, internists, family physicians and other physicians: analysis of a large statewide database. Am Heart J 2000;139:491-6.